Research groups
Colleges
Najib M Rahman
BM BCh MA (oxon) MSc (LSHTM) FRCP DPhil
Professor of Respiratory Medicine, Director ORTU
- Director, Oxford Respiratory Trials Unit (ORTU).
- Group Head / PI
- Consultant Physician
- National Speciality Lead, Respiratory Disorders, NIHR CRN
- NIHR Senior Investigator
About me
I am Director of the Oxford Respiratory Trials Unit (ORTU).
My personal research area is pleural disease, for which I received MRC Training Fellowship funding to conduct my DPhil. My group has designed and led multiple multicentre randomised trials in pleural disease which have altered treatment for thousands of patients per year, and appear in national and international guidelines. This includes diagnostics in malignant effusion, treatment of malignant effusion, pleural infection and pneumothorax, and the use of ultrasound and thoracoscopy.
In parallel, I lead the Translational Pleural Laboratory, which utilises clinical samples linked to diagnosis and key clinical outcome data to understand the pathobiology of pleural disease, and identify potential new areas of treatment.
Ongoing Research
Our current programme of research is focussed on
1. Practice changing pragmatic trials in all areas of respiratory medicine through collaborative multicentre phase 3 studies (NIHR and HTA funding).
2. Translational science using pleural fluid and pleural biopsies to delineate underlying pathology, phenotype and treatment targets (funded via the Oxford NIHR BRC).
3. Collaborative work across a number of different academic areas including radiology, oncology, surgery and imaging.
Key publications
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
Journal article
Butler CC. et al, (2023), Lancet, 401, 281 - 293
Ambulatory management of primary spontaneous pneumothorax: an open-label, randomised controlled trial.
Journal article
Hallifax RJ. et al, (2020), Lancet, 396, 39 - 49
Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain Control and Pleurodesis Efficacy Among Patients With Malignant Pleural Effusion: The TIME1 Randomized Clinical Trial.
Journal article
Rahman NM. et al, (2015), JAMA, 314, 2641 - 2653
Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial.
Journal article
Davies HE. et al, (2012), JAMA, 307, 2383 - 2389
Intrapleural use of tissue plasminogen activator and DNase in pleural infection
Journal article
Rahman NM. et al, (2011), New England Journal of Medicine, 365, 518 - 526
Recent publications
Nirmatrelvir-ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022-23: virological and immunological results of an open-label randomised trial (PANORAMIC).
Journal article
Lowe DM. et al, (2027), Lancet Microbe
Global trends in pleural infection mortality: a WHO-mortality database analysis
Journal article
Gonnelli F. et al, (2026), ERJ Open Research, 00551 - 2026
Pleural Infection in Adults: Integrating Medical and Surgical Management for Optimal Outcomes.
Journal article
Bhatnagar M. et al, (2026), Thorac Surg Clin, 36, 293 - 304
Qualitative insights into patient and carer perspectives of malignant pleural effusion management: an embedded study within the TACTIC trial.
Journal article
Milne A. et al, (2026), BMJ Open Respir Res, 13
Pleural Management Pathways and Outcomes in Haematological Malignancy-Associated Malignant Pleural Effusion.
Journal article
Walsh O. et al, (2026), J Clin Med, 15
Protocol for Mesothelioma Observational study of Risk prediction and Generation of paired benign-meso tissue samples, Including a Nested MRI Substudy (Meso-ORIGINS).
Journal article
Neilly MDJ. et al, (2026), BMJ Open Respir Res, 13
Aetiology, management and outcomes of eosinophilic pleural effusion: data from the International Multicentre Pleural Research Collaborative.
Journal article
Krenke R. et al, (2026), ERJ Open Res, 12
Patient perspectives on ultrasound-guided interventions in respiratory medicine: an international, mixed-methods study.
Journal article
Jones E. et al, (2026), ERJ Open Res, 12
Training in pleural interventions: not just a matter of 'rights'?
Journal article
Stanton AE. et al, (2026), BMJ Open Respir Res, 13
Diagnostic Performance of Thoracic Ultrasound and Shear Wave Elastography in Detecting Malignant Pleural Effusion: A Comprehensive Systematic Review and Meta-analysis of Different Ultrasonographic Signs
Journal article
Msherghi A. et al, (2026), ERJ Open Research, 01658 - 02025
Extracellular stressors change BBSome expression of benign mesothelial and primary pleural mesothelioma cells and affect cell adhesion and migration.
Journal article
Jagirdar RM. et al, (2026), Physiol Rep, 14
Outperformed by enzymes: why saline lavage falls short of intrapleural enzyme therapy in pleural infection.
Journal article
Lee YCG. and Rahman NM., (2026), Eur Respir J, 67
B14-05 A Randomized Controlled Trial of Cryobiopsy Versus Forceps for Transbronchial Lung Biopsy
Journal article
Thiboutot J. et al, (2026), American Journal of Respiratory and Critical Care Medicine, 212
British Thoracic Society Quality Standard for Pleural Disease.
Journal article
Roberts ME. et al, (2026), BMJ Open Respir Res, 13
Cryobiopsy vs Forceps for Bronchoscopic Lung Biopsy: The FROSTBITE-2 Randomized Clinical Trial.
Journal article
Thiboutot J. et al, (2026), JAMA
A Mixed Methods Evaluation of Pleural Procedural Experience and Training in Intensive Care Trainees
Preprint
Fitzpatrick L. et al, (2026)
Outcomes of radiologically diagnosed solitary fibrous tumours of the pleura.
Journal article
Ellayeh M. et al, (2026), ERJ Open Res, 12
